Attached files

file filename
8-K - CURRENT REPORT - Ipsidy Inc.ea125137-8k_ipsidy.htm

Exhibit 99.1

 

Ipsidy Announces Results for Second Quarter Ended June 30, 2020 Relaunch and Revitalization

LONG BEACH, N.Y., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Ipsidy Inc. (www.ipsidy.com) [OTCQB:IDTY] a leading provider of secure, mobile biometric identity solutions, including Identity as a Service (IDaaS), today announced its results for the second quarter ended June 30, 2020.

Financial Results for the Three Months and Six Months Ended June 30, 2020

·Total revenue for the three and six-month periods in 2020 was $0.3 million and $1.1 million respectively compared to $0.6 million and $1.4 million respectively for the three and six months in 2019. The decrease was principally due to the impact of the Covid-19 pandemic.
·Net loss before taxes for the three and six months ended June 30, 2020 was $3.5 million and $7.3 million respectively, compared to a net loss before taxes for the three and six months ended June 30, 2019 of $2.2 million and $4.4 Million, respectively. 
·The increase resulted primarily from charges relating to the non-cash convertible note financing and warrant exercise “holiday”, impairment charges arising out of the Covid-19 pandemic, severance costs and stock compensation costs for new executives.
·Basic and diluted net loss per share was 0.01 cents in each of the three and six month periods ended June 30, 2020 compared to basic and diluted net loss per share of $0.00 cents and 0.01 cents in the three and six months ended June 30, 2019, respectively.
·Adjusted EBITDA loss for the three and six month periods ended June 30, 2020 was $1.4 million and $2.7 million respectively compared to $1.5 million and $3.1 million respectively in 2019, decreases of 7% and 12% respectively.
·Secured approximately $3 million of additional funding in the six months ended June 30, 2020: $1.5 million through a convertible debt offering in February 2020 and $1.5 million through common equity investment in June 2020.

Refer to Table 1 for reconciliation of net income to Adjusted EBITDA (a non-GAAP measure).

“The last three months have seen positive developments for Ipsidy,” said Phillip Kumnick, CEO & Deputy Chairman of Ipsidy. “We strengthened the Ipsidy team, secured contracts with leading, global banking platforms and technology resellers that broaden our sales and market reach and delivered solution enhancements to provide security and trusted identity via a quick web browser session and to support the growing trends for remote onboarding of customers and ‘touchless’ commerce. Our relaunch in June and outreach to the industry have been well received and although there is much work to be done, we look forward to reporting on further progress in the coming months.” 

 

 

The following highlights of our activities during the first half of 2020 demonstrate execution of our strategy to expand the Ipsidy Partner Network with identity industry and technology professionals, that can effectively deliver our identity services to a range of markets and verticals that are demanding increased security and trust.

·Signed a reseller and technology agreement with Intellicheck, Inc. (NASDAQ: IDN), a provider of identification authentication and age verification technology for North America.
·Entered an agreement with Temenos SA (SIX: TEMN), a global banking software provider to over 3000 financial institutions, including 41 of the world’s top 50 banks, to integrate with the Temenos banking software system and become a member of the Temenos MarketPlace which provides financial institutions with easy access to innovative fintech solutions from around the world.
·Executed a reseller agreement with IECISA, a Gfi group company, which provides information technology services in 11 European countries and the Latin America Caribbean region. IECISA is a technology consultant specialized in delivering digital solutions and value-added services to digitally transform companies and public entities through technological innovation, operating in a wide variety of industry verticals, including the finance, telecommunications, media, and security sectors. The Reseller is offering our identity proofing and authentication services with enhanced citizen identity validation through our integrated connection to the Peruvian National Registry, RENIEC.
·Selected by PharmacyID to deliver a high assurance identity verification solution in Australia. PharmacyID, which operates a platform offering a trusted in-person identity verification service through a network of over 2,500 pharmacies, signed a partnership agreement to integrate with the Ipsidy platform to create a state of the art mobile, facial biometric identity verification solution for the Australian market.
·Signed a technology reseller agreement with ATOS Origin FZ LLC (a part of the ATOS Middle East, Turkey & Africa region), a global leader in digital transformation. ATOS will offer Ipsidy’s innovative identity solutions to address the demand in the Middle East for services needed to build trust in today’s online, digital world across major customers in the telecom, media, utilities, financial services and public sector markets.
·Launched our web browser applications, in order to make it easier for more clients to deliver the solution to their users as well as simplify the user experience for both Proof™ our remote onboarding and account takeover fraud prevention solution and Verified™ our biometric multi-factor authentication solution.
·Appointed Phillip L. Kumnick as CEO in May 2020. Mr. Kumnick was previously SVP Global Acquirer Processing at Visa and an experienced industry executive and joined our Board of Directors in December 2019.
·Appointed Philip R. Broenniman as President & COO in May 2020. Mr. Broenniman is an experienced investment manager with business operating and analytical skills and joined our Board of Directors in March 2020.

The identity solutions market is rapidly developing and increasing demand for verifying digital identity during remote onboarding and digital transactions can be seen in our expanding pipeline and recent agreements. While remote access to a broad range of services and networks is not new, the COVID-19 pandemic is accelerating demand for verifying identity seamlessly during remote onboarding as well securing “touchless” interaction. Our mobile biometric services are designed to help organizations thwart identity fraud and account takeover, by knowing the identity of their users with speed and accuracy. We believe Ipsidy’s solutions substantially enhance how they can confidently onboard new users and authenticate their access and services throughout the customer engagement.

We continue to carefully watch developments related to COVID-19. The extent to which COVID-19 will impact our customers, business, results and financial condition will depend on current and future developments, which are highly uncertain and cannot be predicted at this time. Beginning March 2020, the Company’s day-to-day operations have been impacted differently depending on geographic location and services that are being performed. We have seen our business opportunities develop more slowly as business partners and potential customers are dealing with Covid-19 issues and working remotely. These issues have caused delays in decision making and finalization of negotiations and agreements but at the same time we have seen an uptick in interest in our solutions, and we are optimistic that these will start to bear fruit. We appreciate the support of our employees, partners and customers in these difficult times.

Additional analysis of the Company’s performance can be found in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in the Quarterly Report on Form 10-K for the three and six months ended June 30, 2020 filed at www.sec.gov and posted on the Company’s investor relations website.

2

 

About Ipsidy:
Ipsidy Inc. (OTCQB:IDTY) www.ipsidy.com, is Digital Identity. Ipsidy’s mission is to ensure our customers know the identity of their users with biometric certainty. Our Identity as a Service (IDaaS) platform delivers a suite of secure, mobile, facial biometric identity solutions, available to any vertical, anywhere. Our robust identity verification and authentication solutions work great on their own but even better together to help answer everyday questions: Who is applying for a loan? Who is sending money? Who is requesting an account change? Ipsidy is committed to providing seamless, accurate and speedy identity solutions that establish security and trust in today’s digital world.
Ipsidy is headquartered in New York and has operating subsidiaries: MultiPay in Colombia, www.multipay.com.co; Cards Plus in South Africa, www.cardsplus.co.za; Ipsidy Enterprises in the U.K. and Ipsidy Perú S.A.C. Further information on Ipsidy can be found at www.ipsidy.com or contact us at sales@ipsidy.com.

Contacts:

Ipsidy Inc.  
Phillip Kumnick, CEO phillipkumnick@ipsidy.com
Stuart Stoller, CFO stuartstoller@ipsidy.com
  +1 (516) 274-8700

Notice Regarding Forward-Looking Statements.
Information contained in this announcement may include “forward-looking statements.” All statements other than statements of historical facts included herein, including, without limitation, those regarding the financial position, business strategy, plans and objectives of management for future operations of both Ipsidy and its business partners, future service launches with customers, the outcome of pilots and new initiatives and customer pipeline are forward-looking statements. Such forward-looking statements are based on a number of assumptions regarding Ipsidy present and future business strategies, and the environment in which Ipsidy expects to operate in the future, which assumptions may or may not be fulfilled in practice. Implementation of some or all of the new services referred to is subject to regulatory or other third party approvals. Actual results may vary materially from the results anticipated by these forward-looking statements as a result of a variety of risk factors, including the risk that implementation, adoption and offering of the service by customers, consumers and others may take longer than anticipated, or may not occur at all; changes in laws, regulations and practices; changes in domestic and international economic and political conditions, the as yet uncertain impact of the Covid-19 pandemic and others. Additional risks may arise with respect to commencing operations in new countries and regions, of which Ipsidy is not fully aware at this time. See the Company’s Annual Report Form 10-K for the Fiscal Year ended December 31, 2019 filed at www.sec.gov for other risk factors which investors should consider. These forward-looking statements speak only as to the date of this announcement and cannot be relied upon as a guide to future performance. Ipsidy expressly disclaims any obligation or undertaking to disseminate any updates or revisions to any forward-looking statements contained in this announcement to reflect any changes in its expectations with regard thereto or any change in events, conditions or circumstances on which any statement is based.

Non-GAAP Financial Information.
The Company provides certain non-GAAP financial measures in this statement. Management believes that Adjusted EBITDA, when viewed with our results under GAAP and the accompanying reconciliations, provides useful information about our period-over-period results. Adjusted EBITDA is presented because management believes it provides additional information with respect to the performance of our fundamental business activities and is also frequently used by securities analysts, investors and other interested parties in the evaluation of comparable companies. We also rely on Adjusted EBITDA as a primary measure to review and assess the operating performance of our company and our management team in connection with our executive compensation. These non-GAAP key business indicators, which include Adjusted EBITDA, should not be considered replacements for and should be read in conjunction with the GAAP financial measures.

We define Adjusted EBITDA as GAAP net loss adjusted to exclude: (1) interest expense, (2) interest income, (3) provision for income taxes, (4) depreciation and amortization, (5)

stock-based compensation expense (stock options and restricted stock) and (6) certain other items management believes affect the comparability of operating results. Please see Table 1 below for a reconciliation of Adjusted EBITDA to net income (loss), the most directly comparable financial measure calculated and presented in accordance with GAAP.

3

 

TABLE 1

Reconciliation of Net Loss to Adjusted EBITDA
(Unaudited)

   For the Three Months Ended   For the Six Months Ended 
   June 30,
2020
   June 30,
2019
   June 30,
2020
   June 30,
2019
 
                 
                 
Net loss  $(3,462,448)  $(2,175,791)  $(7,298,869)  $(4,438,530)
                     
Add Back:                    
                     
Interest Expense   310,153    93,260    489,203    180,150 
Other expense/(income)   342,082    (6,271)   1,317,971    (12,497)
Severance cost   426,175    -      426,175    -   
Depreciation and amortization   321,987    166,908    647,331    327,696 
Taxes   3,592    4,264    12,466    17,965 
Impairment loss   163,822    -      1,035,629    -   
Stock compensation   460,883    372,341    629,993    787,720 
                     
Adjusted EBITDA (Non-GAAP)  $(1,433,754)  $(1,545,289)  $(2,740,101)  $(3,137,496)

 

4

 

IPSIDY INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)

   Three Months ended   Six Months Ended 
   June 30,   June 30, 
   2020   2019   2020   2019 
                 
Revenues:                    
Products and services  $306,692   $628,905   $1,085,630   $1,352,846 
Lease income   14,427    16,056    29,278    32,493 
Total revenues, net   321,119    644,961    1,114,908    1,385,339 
                     
Operating Expenses:                    
Cost of sales   61,798    189,261    417,521    365,724 
General and administrative   2,389,794    2,007,038    3,872,916    4,147,869 
Research and development   190,339    366,292    620,740    796,962 
Impairment loss   163,822    -      1,035,629    -   
Depreciation and amortization   321,987    166,908    647,331    327,696 
Total operating expenses   3,127,740    2,729,499    6,594,137    5,638,251 
                     
Loss from operations   (2,806,621)   (2,084,538)   (5,479,229)   (4,252,912)
                     
Other Income (Expense):                    
Interest expense   (310,153)   (93,260)   (489,203)   (180,150)
Other (expense) income, net   (342,082)   6,271    (1,317,971)   12,497 
Other expense, net   (652,235)   (86,989)   (1,807,174)   (167,653)
                     
Loss before income taxes   (3,458,856)   (2,171,527)   (7,286,403)   (4,420,565)
                     
Income tax expense   (3,592)   (4,264)   (12,466)   (17,965)
                     
Net loss  $(3,462,448)  $(2,175,791)  $(7,298,869)  $(4,438,530)
                     
Net loss per share - Basic and Diluted  $(0.01)  $(0.00)  $(0.01)  $(0.01)
                     
Weighted Average Shares Outstanding - Basic and Diluted   523,234,921    479,787,679    524,207,499    476,369,338 

 

See notes to condensed consolidated financial statements. 

5

 

IPSIDY INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS

   June 30,   December 31, 
   2020   2019 
   (unaudited)     
ASSETS
Current Assets:          
Cash  $814,950   $567,081 
Accounts receivable, net   158,635    125,859 
Stock subscription receivable   965,033    -   
Current portion of net investment in direct financing lease   68,909    65,333 
Inventory, net   162,435    173,575 
Other current assets   379,139    753,505 
Total current assets   2,549,101    1,685,353 
           
Property and equipment, net   113,815    161,820 
Other assets   241,600    383,066 
Intangible assets, net   5,272,041    5,593,612 
Goodwill   4,183,232    5,218,861 
Net investment in direct financing lease, net of current portion   459,331    494,703 
Total assets  $12,819,120   $13,537,415 
           
LIABILITIES AND STOCKHOLDERS' EQUITY          
Current Liabilities:          
Accounts payable and accrued expenses  $2,655,107   $2,215,912 
Notes payable, current portion   5,635    5,341 
Capital lease obligation, current portion   36,958    34,816 
Deferred revenue   454,086    425,276 
Total current liabilities   3,151,786    2,681,345 
           
Long-term liabilities:          
Notes payable, net of discounts and current portion   490,392    1,970,937 
Convertible debt, net of discounts   5,563,538    428,000 
Capital lease obligation, net of current portion   30,764    49,794 
Operating lease liabilities   92,503    131,568 
Total liabilities   9,328,983    5,261,644 
           
Commitments and Contingencies (Note 12)          
           
Stockholders' Equity:          
Common stock, $0.0001 par value, 1,000,000,000 shares authorized; 546,654,196 and 518,125,454 shares issued and outstanding as of June 30, 2020 and December 31, 2019, respectively   54,665    51,812 
Additional paid in capital   97,528,578    94,982,167 
Accumulated deficit   (94,234,462)   (86,935,593)
Accumulated comprehensive income   141,356    177,385 
Total stockholders' equity   3,490,137    8,275,771 
Total liabilities and stockholders' equity  $12,819,120   $13,537,415 

 

See notes to condensed consolidated financial statements.

6

 

 IPSIDY INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)

   For the Six Months Ended 
   June 30, 
   2020   2019 
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net loss  $(7,298,869)  $(4,438,530)
Adjustments to reconcile net loss with cash used in operations:          
Depreciation and amortization expense   600,978    327,696 
Stock-based compensation   629,993    787,720 
Extinguishment of note payable   985,481      
Amortization of debt discount and debt issuance costs, net   214,668    54,882 
Common stock issued for services   -      41,112 
Warrant exercise inducement expense   366,795    -   
Impairment loss/write-off of assets   1,059,495    -   
Changes in operating assets and liabilities:          
Accounts receivable   (23,217)   (63,869)
Net investment in direct financing lease   31,796    28,581 
Inventory   21,984    (60,818)
Other current assets   374,366    155,035 
Accounts payable and accrued expenses   1,056,433    324,076 
Deferred revenue   28,810    173,518 
Net cash flows from operating activities   (1,951,287)   (2,670,597)
           
CASH FLOWS FROM INVESTING ACTIVITIES:          
Purchase of property and equipment   (2,394)   (14,902)
Decrease in other assets   13,462    -   
Investment in other assets including work in process   (124,870)   (940,068)
Net cash flows from investing activities   (113,802)   (954,970)
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Proceeds from issuance of convertible note payable   1,510,000    -   
Payment of debt issuance costs   (104,800)   -   
Proceeds from sale of common stock offering, net of offering costs   200,000    2,832,152 
Proceeds from the exercise of warrants   283,950    -   
Proceeds from the payroll protection loan   485,760    -   
Principal payments on capital lease obligations and notes payable   (19,487)   (14,987)
Net cash flows from financing activities   2,355,423    2,817,165 
           
Effect of foreign currencies exchange on cash   (42,465)   20,291 
           
Net change in Cash   247,869    (788,111)
Cash, Beginning of Period   567,081    4,972,331 
Cash, End of Period  $814,950   $4,184,220 
           
Supplemental Disclosure of Cash Flow Information:          
Cash paid for interest  $5,296   $4,223 
Cash paid for income taxes  $12,466   $13,701 
           
Non-cash Investing and Financing Activities:          
Modification of warrants issued with convertible debt  $95,223   $-   
Exchange of notes payable and accrued interest for convertible notes payable  $2,662,000   $-   
Warrant exercise with a subscription receivable  $965,033   $-   
Settlement of accounts payable with common stock  $8,270   $-   
Purchase of vehicle with note payable  $-     $16,510 
Recognition of lease right to use assets and liabilities  $-     $514,473 
Reclassification of software development to intangible costs  $252,875   $-   

See notes to condensed consolidated financial statements.

 

7